Children's Hospital and Reasearch Center Oakland
Oakland, California, 94609, United States
NCT Number: NCT02044757
The purpose of this study to investigate the addictive properties of soda and other sugar sweetened beverages (SBBs) in teenagers aged 13-18 years. It is hypothesized that participants who were regularly consuming sweetened and caffeinated beverages will experience symptoms typical of caffeine withdrawal, such as headache and fatigue, during the SSB withdrawal period.
Looking for future studies?
Notify Me13 year–18 year
All sexes
Interventional
Not applicable
Oakland, California, 94609, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
During days 1-5, participants will drink the beverages they normally consume (no intervention). On days 6-8, participants will be instructed to drink only water and unflavored milk during the withdrawal period (days 6-8).
Time frame: Days 1-3 and days 6-8
Symptoms of withdrawal during the SSB withdrawal period (days 6-8) will be compared to symptoms of withdrawal during usual consumption period (days 1-3). Three measures are used to assess withdrawal symptoms: Griffiths' withdrawal scale, the relative reinforcing value of soda, and daily check in questions on well-being.
Time frame: Days 1-2, 6-8
Changes in diet will be assessed by 24-hour dietary recalls and beverage recalls
Time frame: Days 1 and 8
Impulsivity will be assessed via the delayed discounting task
Time frame: Days 1 and 8
Stress will be assessed via salivary cortisol samples
Time frame: Days 1-3, 6-8
Preference for soda will be measured through the Labeled Affective Magnitude Scale (LAMS) and daily check-in questions
Time frame: Days 6-8
Using measure of salivary caffeine, beverage recalls, and 24-hour dietary recalls, we will assess compliance.
University of California, Berkeley
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03557294
Behavior, Chemically-Induced Disorders
Phoenix, Arizona, United States
View Trial DetailsNCT02391571
Chemically-Induced Disorders, Mental Disorders
Overland Park, Kansas, United States
View Trial DetailsNCT05834478
Chemically-Induced Disorders, Mental Disorders
Atlanta, Georgia, United States
View Trial DetailsNCT00480441
Behavior, Behavior, Addictive
Philadelphia, Pennsylvania, United States
View Trial Details